Basics Organogenesis Holdings Inc. IPO Date: January 2, 2017 Sector: Healthcare Industry: Drug Manufacturers - Specialty and Generic Market Cap: $376.76M Activated in VL: True Average Daily Range Avg Daily Range: $0.31 | 3.65% Avg Daily Range (30 D): $0.13 | 3.45% Avg Daily Range (90 D): $0.17 | 3.93% Institutional Daily Volume Avg Daily Volume: .58M Avg Daily Volume (30 D): 1.29M Avg Daily Volume (90 D): 1.54M Trade Size Avg Trade Size (Sh.): 118 Avg Trade Size (Sh.) (30 D): 126 Avg Trade Size (Sh.) (90 D): 132 Institutional Trades Total Inst.Trades: 812 Avg Inst. Trade: $2.35M Avg Inst. Trade (30 D): $2.14M Avg Inst. Trade (90 D): $2.11M Avg Inst. Trade Volume: .36M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.17M Avg Closing Trade (30 D): $.72M Avg Closing Trade (90 D): $1.17M Avg Closing Volume: 263.38K     News Feb 28, 2025 @ 5:45 AM Organogenesis (ORGO) Q4 2024 Earnings Call Transcr... Source: The Motley Fool Jun 6, 2024 @ 8:05 PM Organogenesis Holdings Inc. to Participate in theÃ... Source: Organogenesis Holdings Inc. May 10, 2024 @ 12:45 AM Organogenesis (ORGO) Q1 2024 Earnings Call Transcr... Source: newsfeedback@fool.com (Motley Fool Transcribing) Apr 16, 2024 @ 11:30 AM Organogenesis Holdings Inc. to Report First Quarte... Source: Organogenesis Holdings Inc. Apr 3, 2024 @ 11:30 AM Organogenesis Announces Favorable Court Ruling Dis... Source: Organogenesis Holdings Inc. Financials   TTM Q3 2024 Q2 2024 Basic EPS $-.17 $.09 $-.13 Diluted EPS $-.17 $.09 $-.13 Revenue $ 86.69M $ 115.18M $ 130.23M Gross Profit $ 62.97M $ 88.38M $ 101.04M Net Income / Loss $ -18.84M $ 12.33M $ -17.04M Operating Income / Loss $ -26.75M $ 6.24M $ -13.89M Cost of Revenue $ 23.72M $ 26.8M $ 29.2M Net Cash Flow $ -25.62M $ 4.45M $ 1.13M PE Ratio